Skip to main content

Advertisement

SpringerLink
Log in

Immunopathogenesis of Behçet’s disease with special emphasize on the possible role of antigen presenting cells

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Behçet’s disease (BD) is a systemic vasculitis with unclear etiology and pathogenesis. Although several viral and bacterial causes have been investigated in detail for several years, of late it is widely accepted that microorganisms may play a role as a trigger, or as a cross-reactive antigens that interfere with self-antigens, such as heat-shock proteins. Genes such as HLA-B51, MICA and TNF, considered to play a crucial role in the pathogenesis of BD, are located in the major histocompatibility complex (MHC). However, it has been accepted that, only HLA-B51 is directly related with pathogenesis of the disease, and others have strong linkage disequilibrium with HLA-B51. Some other genes such as IL1, Factor V and ICAM-1, KIR and eNOS assumed to take a part in the pathogenesis are settled out of the MHC region. In patients with BD, several abnormalities in innate and acquired immunity were detected. Mainly, the hypersensitivity of T lymphocytes to different types of antigens plays a critical role in the pathogenesis. However, it is not clear that whether defective signal transduction or antigen presenting cell (APC) dysfunction is responsible for T cell hypersensitivity. Cytokines and chemokines secreted from APCs and T cells are suggested to cause the neutrophil hyperactivation. Activated neutrophils secrete some cytokines, which prime themselves and also stimulate Th1 cells. These relationships among APCs, Th1 lymphocytes and neutrophils constitute the basis of immune responses in BD. In this review, we focus on the possible role of APC in the pathogenesis of BD with an attempt to take attention of researchers in this field to these cells at the crossroads of innate and adaptive immunity, and discuss other potential contributors including cells of the immune system and mediators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ergun T, Gurbuz O, Harvell J, Jorizzo J, White W (1998) The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behcet’s disease. Int J Dermatol 37:929–933

    Article  PubMed  CAS  Google Scholar 

  2. Gul A, Esin S, Dilsen N, Konice M, Wigzell H et al (1995) Immunohistology of skin pathergy reaction in Behcet’s disease. Br J Dermatol 132:901–907

    Article  PubMed  CAS  Google Scholar 

  3. Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet’s disease. Int Rev Immunol 14:21–32

    PubMed  CAS  Google Scholar 

  4. Lee ES, Lee S, Bang D, Sohn S (1997) Herpes simpleks virus detection by polymerase chain reaction in intestinal ulcer of patients with Behçet’s disease. In: Hamza M (ed) Proceedings of the 7th international conference on Behçet’s disease. 71–4 (abstract)

  5. Sohn S, Lee ES, Bang D, Lee S (1998) Behcet’s disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 8:21–23

    PubMed  CAS  Google Scholar 

  6. Çalguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I (1996) The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet’s disease. A randomized clinical trial. Arthritis Rheum 39:2062–2065

    Article  PubMed  Google Scholar 

  7. Çalguneri M, Ertenli I, Kiraz S, Erman M, Celik I (1996) Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet’s disease. Dermatology 192:125–128

    PubMed  Google Scholar 

  8. The Behcet’s Disease Research Committee of Japan (1989) Skin hypersensitivity to streptococal antigens and the induction of systemic symptoms by the antigens in Behçet’s disease—a multicenter study. J Rheumatol 1989(16):506–511

  9. Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet’s disease. Cell Immunol 140:410–409

    Article  PubMed  CAS  Google Scholar 

  10. Hirohata S, Hashimoto T (1998) Abnormal T cell responses to bacterial superantigens in Behcet’s disease (BD). Clin Exp Immunol 112:317–324

    Article  PubMed  CAS  Google Scholar 

  11. Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet’s disease. Med Microbiol Immunol (Berl) 192:149–155

    Article  CAS  Google Scholar 

  12. Ergun T, Ince U, Eksioglu-Demiralp E et al (2001) HSP 60 expression in mucocutaneous lesions of Behcet’s disease. J Am Acad Dermatol 45:904–909

    Article  PubMed  CAS  Google Scholar 

  13. Hasan A, Fortune F, Wilson A et al (1996) Role of gamma delta T cells in pathogenesis and diagnosis of Behcet’s disease. Lancet 23(347):789–794

    Article  Google Scholar 

  14. Pervin K, Childerstone A, Shinnick T et al (1993) T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet’s disease. J Immunol 15(151):2273–2282

    Google Scholar 

  15. Kaneko S, Suzuki N, Yamashita N et al (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet’s disease (BD) in Japan. Clin Exp Immunol 108:204–212

    Article  PubMed  CAS  Google Scholar 

  16. Stanford MR, Kasp E, Whiston R et al (1994) Heat shock protein peptides reactive in patients with Behcet’s disease are uveitogenic in Lewis rats. Clin Exp Immunol 97:226–231

    Article  PubMed  CAS  Google Scholar 

  17. Hu W, Hasan A, Wilson A et al (1998) Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336–351. Eur J Immunol 28:2444–2455

    Article  PubMed  CAS  Google Scholar 

  18. Isogai E, Isogai H, Kimura K, Fujii N, Kotake S, Yoshikawa K et al (2000) Infection of genotobiotic mice with streptococcus sangius associated with Behçet’s disease. In: 9th International conference on Behçet’s disease. Yonsei Med J 41(Suppl):L13 P12 (abstract)

  19. Direskeneli H (2001) Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002

    Article  PubMed  CAS  Google Scholar 

  20. Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behcet’s disease. Clin Exp Rheumatol. 4(Suppl):S44–S48

    Google Scholar 

  21. Celet B, Akman-Demir G et al (2000) Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol 247:935–939

    Article  PubMed  CAS  Google Scholar 

  22. Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behcet’s disease. Br J Ophthalmol 77:584–589

    PubMed  CAS  Google Scholar 

  23. W-Mor F, Weinberger A, Cohen IR (2002) Identification of alpha-tropomyosin as a target self-antigen in Behçet’s syndrome. Eur J Immunol 32:356–365

    Article  Google Scholar 

  24. Direskeneli H, Keser G, D’Cruz D et al (1995) Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet’s disease. Clin Rheumatol 14:55–61

    Article  PubMed  CAS  Google Scholar 

  25. Aydıntug AO, Tokgöz G, D’Cruz DP et al (1993) Antibodies to endothelial cells in patients with Behçet’s disease. Clin Immunol Immunopathol 67:157–162

    Article  PubMed  Google Scholar 

  26. Dinç A, Takafuta T, Jiang D, Melikoğlu M, Saruhan-Direskeneli G, Shapiro SS (2003) Anti-endothelial cell antibodies in Behçet’s disease. Clin Exp Rheumatol 21(Suppl):S27–S30

    PubMed  Google Scholar 

  27. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M (1998) Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behcet’s disease. Invest Ophthalmol Vis Sci 39:996–1004

    PubMed  CAS  Google Scholar 

  28. Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behcet’s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42:1967–1974

    Article  PubMed  CAS  Google Scholar 

  29. Hamzaoui K, Hamzaoul A, Guemira F, Bessioul M, Hamza M, Ayed K (2002) Cytokine profile in Behçet’s disease patients. Scand J Rheumatol 31:205–210

    Article  PubMed  Google Scholar 

  30. Hamzaoui A, Ghrairi H, Ammar J, Zekri S, Guemira F, Hamzaoui K (2003) IL-8 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behcet’s disease. Clin Exp Rheumatol 21(Suppl):S8–S14

    PubMed  CAS  Google Scholar 

  31. Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A (2006) Serum interleukin-18 levels in patients with Behçet’s disease: is its expression associated with disease activity or clinical presentations? Rheumatol Int 26:545–550

    Article  PubMed  CAS  Google Scholar 

  32. Raziuddin S, Al-Dalaan A, Bahabri S, Siraj AK, Al- Sedairy S (1998) Divergent cytokine production profile in Behçet’s disease. Altered Th 1/Th2 cell cytokine pattern. J Rheumatol 25:329–333

    PubMed  CAS  Google Scholar 

  33. Zierhut M, Mizuki N, Ohno S et al (2003) Immunology and functional genomics of Behcet’s disease. Cell Mol Life Sci 60:1903–22

    Article  PubMed  CAS  Google Scholar 

  34. Ertenli I, Kiraz S, Calgüneri M et al (2001) Synovial fluid cytokine levels in Behcet’s disease. Clin Exp Rheumatol 19(Suppl):S37–S41

    PubMed  CAS  Google Scholar 

  35. Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A (2006) Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet’s disease. Does interleukin-1β play a major role in Behçet’s synovitis? Rheumatol Int 26:608–613

    Article  PubMed  CAS  Google Scholar 

  36. Pay S, Erdem H, Serdar M, Dinç A, Şimşek İ, Turan M (2002) Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet’s disease and familial Mediterranean fever? Clin Rheumatol 21:511–515

    Article  PubMed  CAS  Google Scholar 

  37. Erdem H, Pay S, Serdar M, Şimşek İ, Dinç A, Muşabak U, Pekel A, Turan M (2005) Different ELR(+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet’s disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis. Rheumatol Int 26:162–167

    Article  PubMed  CAS  Google Scholar 

  38. Pay S, Pekel A, Simsek I et al (2006) Expression of CXCR-1 and CXCR-2 chemokine receptors on neutrophils in inflammatory arthritides: does persistant expression of CXCR2 contribute to the erosive changes? Joint Bone Spine 2006 (July 18, Epub ahead of print)

  39. Szekanecz Z, Kim J, Koch AE (2003) Chemokines and chemokine reseptors in rheumatoid arthritis. Semin Immunol 15:15–21

    Article  PubMed  CAS  Google Scholar 

  40. Eksioglu-Demiralp E, Kibaroglu A, Direskeneli H et al (1999) Phenotypic characteristics of B cells in Behcet’s disease: increased activity in B cell subsets. J Rheumatol 26:826–832

    PubMed  CAS  Google Scholar 

  41. Freysdottir J, Lau S, Fortune F (1999) Gammadelta T cells in Behcet’s disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 118:451–457

    Article  PubMed  CAS  Google Scholar 

  42. Niwa Y, Mizushima Y (1990) Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behcet’s disease. Clin Exp Immunol 79:353–360

    Article  PubMed  CAS  Google Scholar 

  43. Hirohata S, Kikuchi H (2003) Behcet’s disease. Arthritis Res Ther 5:139–46

    Article  PubMed  CAS  Google Scholar 

  44. Witowski J, Pawlaczyk K, Breborowicz A et al (2000) IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 15(165):5814–5821

    Google Scholar 

  45. Leung BP, Culshaw S, Gracie JA et al (2001) A role for IL-18 in neutrophil activation. J Immunol 167:2879–86

    PubMed  CAS  Google Scholar 

  46. Cassatella MA (1999) Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 73:369–509

    Article  PubMed  CAS  Google Scholar 

  47. Yamashiro S, Kamohara H, Wang JM et al (2001) Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophilis are heterogeneous and enhance adaptive immune responses. J Leukoc Biol 69:698–704

    PubMed  CAS  Google Scholar 

  48. Sakane T, Suzuki N, Takeno M (1998) Innate and acquired immunity in Behçet’s disease. In: 8th International conference on Behçet’s disease. Program and abstracts. p 56 (abstract)

  49. Takeno M, Shimoyama Y, Suzuki N, Sakane T (1998) Prolonged survival of auto-primed neutrophils from patients with Behçet’s disease. In: 8th International conference on Behçet’s disease. Program and abstracts. p 57 (abstract)

  50. Saito T, Honma T, Saigo K (1980) Epidermal Langerhans’ cell after the prick test for Behçet’s disease. Dermatologica 161:152–156

    Article  PubMed  CAS  Google Scholar 

  51. Kohn S, Haim S, Gilhar A, Friedman-Birnbaum R, Nir I (1980) Epidermal Langerhans’ cells in Behçet’s disease. J Clin Pathol 37:616–619

    Google Scholar 

  52. Kürkçüoğlu N, Çakar N (1988) Epidermal Langerhans’ cells in Behçet’s disease. Australas J Dermatol 29:185–187

    PubMed  Google Scholar 

  53. Mege JL, Dilsen N, Sanguedolce V et al (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20(9):1544–1549

    PubMed  CAS  Google Scholar 

  54. Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet’s disease. Rheumatology (Oxford) 42:860–864

    Article  CAS  Google Scholar 

  55. Boiardi L, Salvarni C, Casali B et al (2004) Single-nucleotide polymorphism located at position-607 of IL-18 gene promotor region in Behçet’s disease. Arthritis Rheum 9(Suppl):S232

    Google Scholar 

  56. Kötter I, Koch R, Vonthein R et al (2005) Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behcet’s disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol 23(4 Suppl 38):S20–S26

    PubMed  Google Scholar 

  57. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Ann Rev Immunol 23:307–336

    Article  CAS  Google Scholar 

  58. Pay S, Simsek I, Erdem H et al (2006) Quantitative and functional analysis of dendritic cell subsets in Behçet’s disease: does functional abnormality in plasmacytoid dendtritic cell contribute to Th1 polarization? In: 12th International conference on Behçet’s disease, Lisbon (abstract)

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, Gülhane Military School of Medicine, Etlik/Ankara, 06018, Turkey

    Salih Pay, İsmail Şimşek, Hakan Erdem & Ayhan Dinç

Authors
  1. Salih Pay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. İsmail Şimşek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hakan Erdem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ayhan Dinç
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salih Pay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pay, S., Şimşek, İ., Erdem, H. et al. Immunopathogenesis of Behçet’s disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 27, 417–424 (2007). https://doi.org/10.1007/s00296-006-0281-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-006-0281-6

Keywords

Search

Navigation